Physician profile
Crystal Weber
NPI 1528636982
$622.95
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.28 · 2023: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $606.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $117.47 | 2023 | |
| Abbvie INC. | $78.51 | 2023 | |
| Neurocrine Biosciences, INC. | $63.62 | 2023 | Ingrezza |
| Alkermes, INC. | $48.82 | 2023 | Aristada, Lybalvi |
| Novo Nordisk INC | $39.71 | 2023 | Ozempic, Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $37.85 | 2023 | Trintellix |
| Lundbeck LLC | $33.38 | 2023 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $32.09 | 2023 | Rexulti, Nuedexta |
| Astrazeneca Pharmaceuticals LP | $26.74 | 2023 | Breztri |
| Axsome Therapeutics, INC. | $22.10 | 2023 | Auvelity |
| Sage Therapeutics, LLC | $19.94 | 2023 | |
| Indivior INC. | $19.50 | 2023 | Perseris |
| Exact Sciences Corporation | $18.91 | 2023 | Cologuard Collection Kit |
| Ironshore Pharmaceuticals INC. | $17.78 | 2023 | Jornay Pm |
| Kaleo, INC. | $16.28 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.90 | 2023 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $14.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.